Show simple item record

dc.contributor.authorKemp, Claudio [UNIFESP]
dc.contributor.authorElias, Simone [UNIFESP]
dc.contributor.authorGebrim, Luiz Henrique [UNIFESP]
dc.contributor.authorNazário, Afonso Celso Pinto [UNIFESP]
dc.contributor.authorBaracat, Edmund Chada [UNIFESP]
dc.contributor.authorLima, Geraldo Rodrigues De [UNIFESP]
dc.date.accessioned2015-06-14T13:31:39Z
dc.date.available2015-06-14T13:31:39Z
dc.date.issued2005-07-01
dc.identifierhttp://dx.doi.org/10.1590/S0100-72032005000700008
dc.identifier.citationRevista Brasileira de Ginecologia e Obstetrícia. Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, v. 27, n. 7, p. 415-420, 2005.
dc.identifier.issn0100-7203
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/2589
dc.description.abstractPURPOSE: to evaluate the cost of preventive mammographic screening in climacteric women, as compared to the cost of breast cancer treatment in more advanced stages. METHODS: one thousand and fourteen patients attended at the Climacteric outpatient service of the Gynecology Department, Federal University of São Paulo Paulista School of Medicine, were included in the study and submitted to mammographic test. All mammographic test's were analyzed by the same two physicians and classified according to the BI-RADS (Breast Imaging Reporting and Data System American College of Radiology) categories. The detected lesions were submitted to cytological and histological examination. RESULTS: the final diagnostic impression of the 1014 examinations, according to the classification of BI-RADS categories was: 1=261, 2=671, 3=59, 4=22 and 5=1. The invasive procedures were performed through a needle guided by ultrasound or stereotactic examinations: 33 fine-needle aspiration biopsies, 6 core biopsies guided by ultrasound and 20 core biopsies guided by stereotactic examination. Five cancer diagnoses were established. The total cost of this screening based on Brazilian procedure values was R$ 76,593.79 (25,534 dollars). Therefore, the cost of the diagnosis of the five cases of cancer in this screening was R$ 15,318.75 (5,106 dollars) each. However, the average cost per patient screened was R$ 75.53 (25 dollars). CONCLUSIONS: considering that the total treatment cost of only one case of breast cancer in advanced stage including hospital costs, surgery, chemotherapy, radiotherapy and hormonal treatment is similar to the cost of 1,000 mammographic screenings in climacteric women, it may be concluded that the cost of the early cancer diagnosis program is worth it and should be included in the public health program, as a way of lowering the public health expense.en
dc.description.abstractOBJETIVOS: analisar os custos de um ciclo de rastreamento mamográfico do câncer de mama em população de 1014 mulheres no climatério e comparar com os custos do tratamento do câncer da mama em estádios mais avançados. MÉTODOS: realizou-se rastreamento em 1014 mulheres atendidas em ambulatório de Climatério. Todas as mamografias foram classificadas de acordo com as categorias do BI-RADSä (Breast Imaging Reporting and Data System American College of Radiology) e as lesões detectadas foram submetidas a estudo citológico ou histológico. A estimativa dos custos dos exames e procedimentos realizados foram obtidos da Tabela AMB 92. RESULTADOS: a impressão diagnóstica final dos 1014 exames, de acordo com a classificação em categorias do BI-RADSä, foi: 1=261; 2=671; 3=59; 4=22; 5=1. Os procedimentos invasivos realizados totalizaram 33 punções com agulha fina dirigida por USG, 6 biópsias com agulha grossa orientada por USG e 20 biópsias orientadas por mamografia (estereotaxia). Com base nos valores da tabela AMB 92, foram necessários para rastrear e diagnosticar essa população cerca de R$ 76.000,00. Detectaram-se 5 cânceres de mama, ao custo aproximado de R$ 15.318,75 por diagnóstico e média de custo por paciente de R$ 75,53. CONCLUSÕES: considerando que o custo total do tratamento de um único caso de câncer de mama em estádio II ou mais pode atingir R$ 75.000,00, concluímos que os programas de rastreamento mamográfico podem ser incluídos entre as políticas de saúde.pt
dc.format.extent415-420
dc.language.isopor
dc.publisherFederação Brasileira das Sociedades de Ginecologia e Obstetrícia
dc.relation.ispartofRevista Brasileira de Ginecologia e Obstetrícia
dc.rightsAcesso aberto
dc.subjectBreast neoplasmsen
dc.subjectMammographyen
dc.subjectClimactericen
dc.subjectNeoplasias mamáriaspt
dc.subjectMamografiapt
dc.subjectClimatériopt
dc.titleEstimativa de custo do rastreamento mamográfico em mulheres no climatériopt
dc.title.alternativeCost estimate of mammographic screening in climacteric womenen
dc.typeArtigo
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.description.affiliationUniversidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Departamento de Ginecologia
dc.description.affiliationUnifespUNIFESP, EPM, Depto. de Ginecologia
dc.identifier.fileS0100-72032005000700008.pdf
dc.identifier.scieloS0100-72032005000700008
dc.identifier.doi10.1590/S0100-72032005000700008
dc.description.sourceSciELO


Files in this item

This item appears in the following Collection(s)

Show simple item record